HUTCHMED (China) Limited (HMDCF)
PNK: HMDCF
· Real-Time Price · USD
3.21
0.01 (0.31%)
At close: Apr 30, 2025, 8:00 PM
0.31% (1D)
| Bid | 2.6 |
| Market Cap | 2.79B |
| Revenue (ttm) | 610.81M |
| Net Income (ttm) | -41.97M |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | -64.1 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.46 |
| Volume | 664 |
| Avg. Volume (20D) | 63.956 |
| Open | 3.81 |
| Previous Close | 3.20 |
| Day's Range | 3.21 - 3.81 |
| 52-Week Range | 3.21 - 3.81 |
| Beta | 0.72 |
About HMDCF
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ...
Sector Healthcare
IPO Date Apr 17, 2014
Employees 1,811
Stock Exchange PNK
Ticker Symbol HMDCF
Website https://www.hutch-med.com